← All patents

US11958849B2

GLS1 inhibitors for treating disease

University of Texas System

Abstract

Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I: Methods of inhibition GLS1 activity in a human or animal subject are also provided.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Maria Emilia Di Francesco
Priority date
July 03, 2014
Filing date
April 25, 2022
Grant date
April 16, 2024
Publication date
April 16, 2024
Language
en
Metadata fetched
August 29, 2026 00:31